The Online Investor
Biotechnology IPOs image Biotechnology IPOs » By The Online Investor Staff, updated Mon., Feb. 6, 1:03 AM
Recent initial public offerings in the Biotechnology IPOs category.

Slide #1. Medpace Holdings, Inc. Initial Public Offering

Company: Medpace Holdings, Inc.
Proposed Symbol: MEDP
Shares Offered: 7,000,000
Price Per Share: $23.00
Over-Allotment: 1,050,000
Description: Medpace Holdings, Inc. ("Medpace") today announced the pricing of its initial public offering of 7,000,000 shares of common stock at a public offering price of $23.00 per share. All of the shares of common stock are being offered by Medpace. In addition, Medpace has granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of common stock from Medpace at the initial public offering price, less underwriting discounts and commissions. Medpace's common stock is expected to begin trading on the NASDAQ Global Select Market on August 11, 2016 under the ticker symbol "MEDP," and the offering is expected to close on August 16, 2016, subject to customary closing conditions.

IPOs: Medpace Holdings, Inc.

List of Biotechnology IPOs in this Slideshow: Company Ticker IPO Date Chimerix, Inc. CMRX 4/11/2013 bluebird bio, Inc. BLUE 6/19/2013 NanoString Technologies, Inc. NSTG Veracyte, Inc. VCYT GlycoMimetics, Inc. GLYC Sorrento Therapeutics, Inc. SRNE Biocept, Inc. BIOC Ignyta RXDX SCYNEXIS SCYX Lantheus Holdings, Inc. LNTH Adeptus Health, Inc. ADPT ContraFect Corporation CFRX Cellectar Biosciences, Inc. CLRB Atara Biotherapeutics, Inc. ATRA Xenon Pharmaceuticals Inc. XENE Coherus BioSciences, Inc. CHRS OpGen OPGN Summit Therapeutics plc SMMT Cellectis CLLS aTyr Pharma, Inc. LIFE Cidara Therapeutics, Inc. CDTX Adaptimmune Therapeutics plc ADAP Benitec Biopharma Limited BNTC REGENXBIO Inc. RGNX WAVE Life Sciences Ltd. WVE BeiGene, Ltd. BGNE Editas Medicine, Inc. EDIT Syndax Pharmaceuticals, Inc. SNDX Intellia Therapeutics, Inc. NTLA Medpace Holdings, Inc. MEDP

Biotechnology IPOs Page |

Copyright © 1998 - 2023, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.